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Cellular proteins and organelles are constantly damaged
as a result of cell-stress, expression of mutated genes or
aging by itself. Autophagy is the principle cellular
mechanism for turnover of damaged organelles and
long-lived proteins. Autophagy is initiated by the forma-
tion of a cytoplasmic double membrane that grows to
make a double membrane vesicle that engulfs intracellu-
lar components. This vesicle is subsequently transported
to and fuses with a lysosome and the content is
degraded by lysosomal hydrolases. Tissue specific,
genetic ablation of core autophagy genes results in neu-
rodegeneration or loss of cardiomyocyte function. Sev-
eral autophagy genes have been identified as tumor
suppressors. We have identified how this catabolic route
may select damaged cellular components. The proteins
p62 (SQSTM1) and NBR1 both contain a UBA domain
that binds ubiquitinated proteins and a peptide motif
(LIR) that directly binds to Atg8-family members (LC3/
GABARAP) located on the forming autophagosomal
membranes. This way, p62 and NBR1 physically link
damaged, ubiquitinated proteins to the forming autop-
hagosomal membrane and lysosomal destruction.
With p62 in focus, we now search for conditions or
components that speed up the autophagic flux. The aim
is to increase the removal of damaged cellular compo-
nents to prevent diseases to develop. On the other side,
autophagy is often directly or indirectly down-regulated
in cancer cells. How this dampening of autophagy could
represent a drug target in particular cancer cells will be
discussed.
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